pharmaceuticals

How Health Care Stocks Responded to the Shelved Health Care Bill

Despite touting himself as an incredible dealmaker and negotiater, Trump faced the biggest defeat of his presidency thus far when legislation to repeal the Affordable Care Act was pulled from ...
Read Full Story »

Monday’s Top Biopharma Movers

A few biopharma stocks made massive runs on Monday morning. The broad markets are holding near their all-time highs, and part of the run up to this level is attributed ...
Read Full Story »

Jefferies Has 4 Red-Hot Biotech and Pharmaceutical Stocks to Buy Now

If any sector is offering value in what really appears to be a very overbought stock market, it is pharmaceutical, including biotechnology. Absolutely battered during the election cycle when rhetoric over ...
Read Full Story »

Wednesday’s Biggest Biopharma Movers

The broad markets inched forward on Wednesday after hitting new highs in what has been known as the Trump rally. Although the SPDR S&P Biotech ETF (NYSEMKT: XBI) was up ...
Read Full Story »

Is Valeant Finished Now That Ackman Is Out of the Picture?

Valeant Pharmaceuticals International Inc. (NYSE: VRX) saw its shares hit a multiyear low on Tuesday after it was announced that Bill Ackman would be selling off his stake in the ...
Read Full Story »

Short Sellers Back Off Major Pharma

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Why One Key Analyst Believes That Valeant Is Kicking the Can in Its Restructuring Deal

Valeant Pharmaceuticals International Inc. (NYSE: VRX) has been in the spotlight for a couple years and is now fighting to stay alive. The company initially brought in new executives and ...
Read Full Story »

Monday’s Top Health Care Stocks Screaming Higher

It seems that markets are slowing down and taking a step back after hitting new highs in what has been known as the Trump rally. Although Monday might be slow ...
Read Full Story »
FDA_logo

Where Merck and Pfizer’s Type 2 Diabetes Treatment Can Go From Here

Merck & Co. Inc. (NYSE: MRK) and Pfizer Inc. (NYSE: PFE) each saw their shares sink early on Monday after they gave an update on their type 2 diabetes treatment. ...
Read Full Story »
Depressed Senior Adult Man With Stacks of Papers and Envelopes

Why Analysts Are Looking at Valeant Pharma Differently After Earnings

Valeant Pharmaceuticals International Inc. (NYSE: VRX) saw its shares hit a multiyear low this past week. There was hope for a turnaround when Joe Papa took over as chief executive officer, but ...
Read Full Story »
graph

Wedbush Has 3 Biotech Stocks to Buy With Massive Upside Potential

Needless to say, the biotech world has had a very difficult 18 months. Even the biggest and the best companies, many of which trade cheaper than big pharmaceutical companies, have ...
Read Full Story »
Good heart health

Thursday’s Top Biopharma Movers

Although the health care sector has been attacked by the U.S. government in the past, it now has one of the brightest outlooks in 2017. Considering that the president aims to ...
Read Full Story »
Female patient on gurney

4 Biopharma Stocks Moving the Market on Wednesday

Markets have hit new intraday highs on Wednesday, continuing to climb in the wake of the White House announcements. Although the health care sector has been attacked by the U.S. ...
Read Full Story »
ashamed businessman

Why Valeant Missed the Mark Despite an Earnings Beat

When Valeant Pharmaceuticals International Inc. (NYSE: VRX) reported its fourth-quarter financial results before the markets opened on Tuesday, the company said that it had $1.26 in EPS and $2.4 billion ...
Read Full Story »
Prescription drugs

Why Short Sellers Are Making a Massive Bet in Major Pharma

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »